Industry News
Pharmaceutical Industry News
FTX’s In-House Performance Coach Is Just as Surprised as You Are
George K. Lerner, a psychiatrist who has worked at the collapsed crypto exchange FTX since last year, said he had no knowledge of wrongdoing at the firm.
Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuits
The money would help pay for addiction treatment and drug education programs in communities across the United States.
Puberty Blockers Can Help Transgender Youth. Is There a Cost?
Puberty blockers can ease transgender youths’ anguish and buy time to weigh options. But concerns are growing about long-term physical effects and other consequences.
Behind Our Reporting on Puberty Blockers
We scoured the scientific evidence, interviewed doctors around the world and spoke to patients and families. Here's a closer look at what we found.
The Disease Took Zara, Then Sara. Could Ayla Be Saved?
Two sisters in one family died from a genetic disorder. Before a third child with the disease was born, doctors hatched a plan to spare her of its effects.
Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Finds
The analysis of 15 years of prescription data showed that the racial disparities are widening.
New Booster Shot Targets Covid Variants More Effectively, Pfizer Says
Federal officials are hoping that encouraging new findings will spur more Americans to get an updated booster before a feared surge in coronavirus cases this winter.
New Covid Variants Are Circulating. Here’s What to Know.
The “nightmare variant” is not as bad as it sounds.
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement
The last remaining defendants in New York’s once-sprawling opioid trial settled on Thursday.
Private Medicare Plans Misled Customers Into Signing Up, Senate Report Says
The report by Senate Democrats points to widespread misbehavior by the plans and the marketing firms they hire.
Indian Drugs, Sold Worldwide, Sometimes Deadly
Deaths believed to be linked to contaminated cough syrups in Gambia have brought attention to loose regulations in India and a lack of testing capacity in poor importing nations.
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases
The dual agreements would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on.
A Surge of Overseas Abortion Pills Blunted the Effects of State Abortion Bans
New data suggests that abortion has declined about 2 percent in the U.S. since the end of Roe, accounting for people who traveled across state lines or ordered pills online.
Covid Symptoms Can Rebound Even If You Don’t Take Paxlovid
A new study found that more than a third of those who recovered from an infection had symptoms recur days or weeks later.
Gene Treatment for Rare Epilepsy Causes Brain Side Effect in 2 Children
The side effect, a buildup of fluid in the brain, led to the death of one of the children and presents a grave setback for a class of personalized medicine.
Some Breast Cancer Patients Could Skip Surgery, Study Suggests
In a small trial, chemotherapy alone was sufficient to treat women with certain kinds of tumors.
As Midterms Near, Biden Warns Republicans Seek to Dismantle Democratic Legislation
The president also vowed to veto a federal abortion ban if Republicans regain control of Congress and seek to pass such legislation, in an interview with MSNBC.
Cough Syrup: What We Know About Tainted Medicine from India
Tainted syrup from India may be connected to the deaths of dozens of children in Gambia, officials said. Indonesia banned cough syrup sales, though the link there is unclear.
FDA Panel Recommends Pulling Preterm Birth Drug From the Market
In use for 11 years, the drug Makena provided a test case of the agency’s controversial accelerated approval program. A post-market study showed the drug was not effective.
Biden Tries to Reassure Voters on Health Care Costs Before Election
At an event in Southern California, the president says his administration is working to keep costs down and warns that Republicans will drive prices higher if they gain power.